Pathological features of experimental bovine leukaemia viral (BLV) infection in rats and rabbits

• Autorzy: Dimitrov P. , Simeonov K. , Todorova K. , Ivanova Z. , Toshkova R. , Shikova E. , Russev R.
• Języki publikacji: EN

Abstrakty

EN

Rabbits and rats were inoculated with material derived from FLK cells producing permanently bovine leukaemia virus (BLV). The viral presence in the inoculum was proved by transmission electron microscopy, immunofluorescence, immunogold labelling demonstrating viral Tax protein, and PCR analysis. About 30 % of the infected animals sustained BLV seropositivity during the experiment, and demonstrated symptoms of lympholeukaemia - clinical manifestation of an immunosuppressive condition, increased number of lymphocytes and lymphoblasts, and preneoplastic lymphoid cell accumulations in the liver, lungs, kidneys, and lymph nodes. BLV DNA, detected by PCR in diseased animals, indicates the role of BLV as an aetiological factor of lympholeukaemia, developed in these animals after BLV infection. The alterations in rats were more pronounced than those in rabbits. The results prove that these two species of laboratory animals, especially rats, are suitable models for the in vivo studies of leukaemogenesis caused by BLV/HTLV infections.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2012
• Tom: 56
• Numer: 2
• Opis fizyczny: p.115-120,fig.,ref.

Twórcy

autor

Dimitrov P.

• Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

autor

Simeonov K.

autor

Todorova K.

autor

Ivanova Z.

autor

Toshkova R.

autor

Shikova E.

autor

Russev R.

Bibliografia

• 1. Alexandersen S., Carpenter S., Christensen J., Storgaard T., Viuff B., Wannemuehler Y., Belousov J., Roth J.A.: Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 1993, 67, 39-52.
• 2. Altaner C., Altanerova V., Ban J., Niwa O., Yokoro K.: Human cells of neural origin are permissive for bovine leukemia virus. Neoplasma 1989, 36, 691-695.
• 3. Altanerova V., Ban J., Altaner C.: Induction of immune deficiency syndrome in rabbits by bovine leukemia virus. AIDS 1989, 3, 755-758.
• 4. Altanerova V., Ban J., Kettmann R., Altaner C.: Induction of leukemia in chicken by bovine leukemia virus due to insertional mutagenesis. Arch Geschwulstforsch 1990, 60, 89-96.
• 5. Altanerova V., Holicova D., Kucerova L., Altaner A., Lairmore M.D., Boris-Lawrie K.: Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology 2004, 329, 434-439.
• 6. Altanerova V., Porteteile D., Kettmann R., Altaner C.: Infection of rats with bovine leukaemia virus: establishment of a virus-producing rat cell line. J Gen Virol 1989, 70, 1929-1932.
• 7. Burny A., Bruck C., Chantrenne H., Cleuter Y., Dekegel D., Ghysdael J., Kettmann R., Leclercq M., Leunen J., Mammerickx M., Portetelle, D.: Bovine leukemia virus: molecular biology and epidemiology. In Viral Oncology, edited by Klein G., Raven Press, New York, USA, 1980, pp. 231-289.
• 8. Carlemalm E., Villiger W., Acetarin J.: Advances in specimen preparation for electron microscopy. A novel low temperature embedding resins and reformulated, Vestopal Experiencia 1980, 36, 740-744.
• 9. Dube S., Bachman S., Spicer T., Love J., Choi D., Esteban E., Ferrer J.F., Poiesz B.J.: Degenerate and specific PCR assays for the detection of bovine leukaemia virus and primate T cell leukaemia/lymphoma virus pol DNA and RNA: phylogenetic comparisons of amplified sequences from cattle and primates from around the world. J Gen Virol 1997, 78, 1389-1398.
• 10. European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. OJ L 222, 24.8.1999, 31-37.
• 11. Harknes J., Wagner J.: The biology and medicine of rabbits and rodents, USA, Williams & Wilkins, 1995, pp. 87-95.
• 12. Manchini G., Carbonara A., Heremans J.: Immunochemistry 1965, 2, 235-254.
• 13. Onuma M., Wada M., Yasutomi Y., Yamamoto M., Okada H.M., Kawakami Y.: Suppression of immunological responses in rabbits experimentally infected with bovine leukemia virus. Vet Microbiol 1990, 25, 131-141.
• 14. Rice N.R., Stephens R.M., Gilden R.V.: Sequence analysis of the bovine leukemia virus genome. In: Enzootic bovine leukosis and bovine leukemia virus. Edited by Burny A. and Mammerickx M., Hague, The Netherlands, Nijhoff; 1987, pp. 115-144.
• 15. Todorova A., Filchev A., Zaharieva S., Sotirov N., Boshkov S.: Studies on some changes in peripheral blood, immune state and pathological alterations in rabbits treated with BLV. Compt Rend Acad Bulg Sci 1995, 48, 135-138.
• 16. Wyatt C.R., Wingett D., White J.S., Buck C.D., Knowles D., Reeves R., Magnuson N.S.: Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction. J Virol 1989, 63, 4498-4506.